Est. 2015 · United Kingdom · USA · Austria
Breast-Cancer-26v2
3rd AnnualInvitation Only

Breast Cancer

USFocus Meeting 2027
Two days, 48 people, one room.
April 16 to 17, 2027
NOPSI Hotel, New Orleans, LA
Support Opportunities →
Dates
April 16-17, 2027
Two-day program
Venue
NOPSI Hotel
New Orleans, LA
Audience
48 by invitation
24 KOLs & 24 fellows
Format
8 sessions · 24 talks
Expert talks + moderated panels

A Curated Room: The People Shaping Practice

Now in its third year, this invitation-only meeting convenes a deliberately small faculty: 24 leading breast oncology KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.

The science tracks where treatment is moving: antibody-drug conjugates in HER2-positive and triple-negative disease, biomarker-driven selection after CDK4/6 progression, chemoimmunotherapy in early stage TNBC, and emerging mechanisms in rare histologies. Every session pairs expert talks with a moderated panel discussion, sustained, close-quarters engagement rather than a lecture hall.

Antibody-Drug ConjugatesPost-CDK4/6 SelectionIO in Early TNBCOral SERDs & ESR1Rare HistologiesHER2+ · Triple-Negative · ER+
Meeting Co-Chairs
Listed alphabetically by surname
Komal-Jhavari
Komal Jhaveri
Memorial Sloan Kettering Cancer Center, New York, NY
Virginia Kaklamani
Virginia Kaklamani
UT Health, San Antonio, TX
Faculty Drawn From
MD Anderson · Memorial Sloan Kettering · Dana-Farber · Mass General · Emory Winship · UCLA and other leading US cancer centers
48
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
Breast Cancer US Focus Meeting 2027

Confirmed Faculty

Listed alphabetically by surname
Yara Abdou
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Nour Abuhadra
Memorial Sloan Kettering Cancer Center, New York, NY
Ajit Bisen
MD Anderson Cancer Center, Houston, TX
Rena Callahan
UCLA, Los Angeles, CA
Chau Dang
Memorial Sloan Kettering Cancer Center, New York, NY
Joshua Drago
Memorial Sloan Kettering Cancer Center, New York, NY
Ana Garrido-Castro
Dana-Farber Cancer Institute, Boston, MA
Antonio Giordano
Dana-Farber Cancer Institute, Boston, MA
Neil Iyengar
Winship Cancer Institute, Emory University, Atlanta, GA
Komal Jhaveri
Memorial Sloan Kettering Cancer Center, New York, NY
Virginia Kaklamani
UT Health San Antonio, San Antonio, TX
Maryam Lustberg
Yale Cancer Center, New Haven, CT
Douglas Marks
NYU Langone Health, New York, NY
Heather McArthur
UT Southwestern Medical Center, Dallas, TX
Jason Mouabbi
MD Anderson Cancer Center, Houston, TX
Julie Nangia
Baylor College of Medicine, Houston, TX
Joyce O’Shaughnessy
Baylor University Medical Center, Dallas, TX
Ruta Rao
Rush University Medical Center, Chicago, IL
Sonya Reid
Vanderbilt-Ingram Cancer Center, Nashville, TN
Sarah Sammons
University of Maryland School of Medicine, Baltimore, MD
Sherry Shen
Memorial Sloan Kettering Cancer Center, New York, NY
Abirami Sivapiragasam
Medical University of South Carolina, Charleston, SC
Hatem Soliman
Moffitt Cancer Center, Tampa, FL
Eleonora Teplinsky
Valley-Mount Sinai Comprehensive Cancer Care, Paramus, NJ
Tiffany Traina
Memorial Sloan Kettering Cancer Center, New York, NY
Adrienne Waks
Dana-Farber Cancer Institute, Boston, MA
Further faculty to be announced
Eight Sessions

Proposed Faculty by Session

15 min
5 min
30 min
20 min
65 min
Optimization of Treatment for Early Stage HER2-Positive Breast Cancer
Moderator
Chau DangMemorial Sloan Kettering Cancer Center, New York, NY
Abirami SivapiragasamMedical University of South Carolina, Charleston, SC
Adrienne WaksDana-Farber Cancer Institute, Boston, MA
Management of HER2+ MBC
Moderator
Ruta RaoRush University Medical Center, Chicago, IL
Joshua DragoMemorial Sloan Kettering Cancer Center, New York, NY
Douglas MarksNYU Langone Health, New York, NY
Evolving Landscape in Management of Metastatic TNBC
Moderator
Ana Garrido-CastroDana-Farber Cancer Institute, Boston, MA
Joyce O'ShaughnessyBaylor University Medical Center, Dallas, TX
Tiffany TrainaMemorial Sloan Kettering Cancer Center, New York, NY
Management of Early Stage TNBC
Moderator
Yara AbdouUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Nour AbuhadraMemorial Sloan Kettering Cancer Center, New York, NY
Heather McArthurUT Southwestern Medical Center, Dallas, TX
Partnership Opportunities Now Open

Bespoke engagement packages for a closed, invitation-only audience

Request the Prospectus →
Simon Mayr
Your Point of Contact
Simon Mayr
Chief Operating Officer, MD Education